Amoy Diagnostics Co (300685.SZ) Stock Price
Amoy Diagnostics Co Price
Over the last 13 years Amoy Diagnostics Co grew revenue by 30.4% annually, reaching 1.20 B CNY. Earnings per share have grown at 34.0% per year over the last 13 years. For Amoy Diagnostics Co, the net margin of 29.9% is up versus 26.1% a few years ago. At today's price the dividend yield works out to roughly 1.54%. The payout ratio is around 35% of earnings. The dividend has grown at 29.4% per year over the past 7 years. The consensus 12-month price target for Amoy Diagnostics Co is 30.09 CNY, about 54.0% above where the stock trades today. Of 9 analysts, 8 rate the stock a buy — an overall Buy consensus.
Amoy Diagnostics Co stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Amoy Diagnostics Co business model & stock analysis
Frequently asked questions about Amoy Diagnostics Co
Analysts currently set an average price target of 29.42 CNY for the Amoy Diagnostics Co stock (median: 30.09 CNY), implying +50.6 % versus the latest price. The consensus is based on 9 analyst ratings.
9 analysts currently rate the Amoy Diagnostics Co stock: 8 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Amoy Diagnostics Co to generate revenue of 1.27 B CNY and earnings per share of 0.90 CNY.
Converted at the current exchange rate, the Amoy Diagnostics Co share trades at 2.61 EUR (19.54 CNY).
The Amoy Diagnostics Co share (300685.SZ) is listed on 1 stock exchanges, including: Shenzhen (300685.SZ).
The expected revenue of Amoy Diagnostics Co is 1.27 B CNY. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Amoy Diagnostics Co is 374.57 M CNY. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Amoy Diagnostics Co is currently 21.63. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Amoy Diagnostics Co stock.
The price-to-sales ratio (P/S) of Amoy Diagnostics Co is currently 6.38. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Amoy Diagnostics Co stock.
The Eulerpool Quality Score for Amoy Diagnostics Co is 8/10.
The ISIN of Amoy Diagnostics Co is CNE1000034D3. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Amoy Diagnostics Co is 300685.SZ. The ticker symbol is used to trade Amoy Diagnostics Co shares on the stock exchange.
Amoy Diagnostics Co stock
Amoy Diagnostics Co Peer Group
Amoy Diagnostics Co Ticker
Amoy Diagnostics Co FIGI
All fundamentals and in-depth analysis of Amoy Diagnostics Co
Our stock analysis for Amoy Diagnostics Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Amoy Diagnostics Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.